GENEMATRIX (109820) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, GENEMATRIX (109820) reported revenue of 10.6 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202510.6 billion KRW-679 million KRW-1.8 billion KRW[source]
202410.0 billion KRW-1.6 billion KRW-3.7 billion KRW[source]
20239.8 billion KRW-2.5 billion KRW-895 million KRW[source]
202211.2 billion KRW-1.5 billion KRW-8.1 billion KRW[source]
202112.1 billion KRW-1.2 billion KRW-988 million KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202527.3 billion KRW9.8 billion KRW17.5 billion KRW[source]
202428.5 billion KRW9.2 billion KRW19.2 billion KRW[source]
202331.4 billion KRW8.2 billion KRW23.1 billion KRW[source]
202231.9 billion KRW7.7 billion KRW24.2 billion KRW[source]
202139.5 billion KRW7.2 billion KRW32.3 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice